Acutus Medical, Inc. Just Filed Its Quarterly Report: Net Loss Per Common ...
Net Loss Per Common Share
Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss per common share excludes the potential impact of the Company’s convertible preferred stock, common stock options and warrants because their effect would be anti-dilutive due to the Company’s net loss. Since the Company had a net loss in the periods presented, basic and diluted net loss per common share are the same.
The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per common share because to do so would be anti-dilutive:
Nine Months Ended September 30,
Shares issuable upon:
2021
2020
(unaudited)
Conversion of Series A Common Equivalent Preferred Stock
6,665,841
—
Exercise of stock options
3,961,959
3,416,345
Exercise of common stock warrants
797,487
956,552
Vesting of PSUs and RSUs
861,638
496,592
Total
12,286,925
4,869,489
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Acutus Medical, Inc.
makes a similar move, sign up!
